ARCHIVES

Jane Henney Said Tentative Choice For FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

Guideline Adherence Improves Early Breast Cancer Survival

August 27, 2004

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012